Regulatory News
Friday, July 22, 2016
BRIEF-FDA to inspect Nicox partner Bausch + Lomb
* Has been informed by its partner Bausch + Lomb, a Valeant
unit, of receipt of a complete response letter from
U.S. FDA concerning latanoprostene bunod
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment